[Troglitazone: its pharmacology and mechanism of action].
Horikoshi
H
H
Research Institute, Sankyo Co., Ltd.
Fujiwara
T
T
D000818:Animals; D002839:Chromans / Q000494:pharmacology* / Q000627:therapeutic use; D003920:Diabetes Mellitus / Q000188:drug therapy; D004195:Disease Models, Animal; D006003:Glycogen / Q000378:metabolism; D006019:Glycolysis / Q000187:drug effects; D006801:Humans; D007004:Hypoglycemic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D007328:Insulin / Q000378:metabolism; D007515:Islets of Langerhans / Q000378:metabolism; D008099:Liver / Q000378:metabolism; D013844:Thiazoles / Q000494:pharmacology* / Q000627:therapeutic use; D045162:Thiazolidinediones; D000077288:Troglitazone
D002839:Chromans; D007004:Hypoglycemic Agents; D007328:Insulin; D013844:Thiazoles; D045162:Thiazolidinediones; D006003:Glycogen; D000077288:Troglitazone